… in children with cerebral palsy by an entirely plausible nnechanism. lt is also our view that
BoNT-A administration may also increase the risk of respiratory adverse events, again by an …

… The aim of the present review was to summarize the outcomes of SDR over a long-term
period and to summarize adverse events, such as the development of spinal abnormalities, in …

… well as, higher adverse event rate [22]. There are no analogous studies in cerebral palsy
that we know of. Even though we had a rather limited number of adverse events even with high …

… occurrence of adverse events by logistic regression analysis. However, all adverse events
disappeared after symptomatic treatment. No treatment related serious adverse events were …

… patients with congenital cerebral palsy. Neonatal risk factors for cerebral palsy include birth
… Adverse events reported included decubitus ulcers, lower extremity fracture at cast removal, …

… The most frequent adverse events were related to common childhood … adverse event was
injection site pain (n = 10). There was no evidence of a cumulative effect on adverse events. …

… demographics, SEMLS surgical procedures, adverse events, and rehabilitation. Detailed
reporting … Of particular concern in this review was the limited reporting of adverse events in the …

… was to analyse the efficacy and adverse events since ITB was … charac teristics, efficacy and
adverse events were registered. The … Most infectious and mechanical adverse events were …

… the adverse events associated with botulinum toxin A (BoNT-A) injections in children with
cerebral palsy (CP)… The aim of this narrative review is to report and analyze the adverse events …

… Both researchers and clinicians are aware of and continue to evaluate the level of risk of
adverse events in children with marked cerebral palsy receiving any intervention (including …